Screener
Oric Pharmaceuticals, Inc. ORIC Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Acquisitions of property and equipment | (2) | (387) |
| Purchases of investments | (77,973) | (64,663) |
| Maturities of investments | 60,000 | 87,500 |
| Net cash (used in) provided by investing activities | (17,975) | 22,450 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock | 60,881 | — |
| Issuance costs associated with financings | (993) | — |
| Payment of deferred issuance costs | — | (242) |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s investing cash flow?
- Oric Pharmaceuticals, Inc. (ORIC) reported investing cash flow of -$17.98M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Oric Pharmaceuticals, Inc.'s investing cash flow decreased by 180.1% year-over-year, from $22.45M to -$17.98M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Oric Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude